Naser Jafari

Naser Jafari is a scientist at Agenus, specializing in immune metabolism with significant expertise in the functional effects of small molecules and T cell engagers, successfully enhancing tumor microenvironment modulation for improved immunotherapy outcomes. Previous roles include postdoctoral associate at Boston University School of Medicine, where Naser investigated tumor microenvironment and exosome signaling related to metabolic diseases, and research scholar at the University of Kentucky College of Medicine, focusing on various molecular mechanisms of breast cancer metastasis and CRISPR-Cas9 applications. Naser's academic background includes a PhD in Cancer Metastasis and extensive training in cellular and molecular biology. Continuing education at Harvard Medical School has further enhanced knowledge in pharmacology, clinical drug development, and immuno-oncology.